Chronic kidney disease (CKD) remains to be one of the highest public health burdens
worldwide with high-prevalence among the general population. The heterogeneity of the …

Introduction: Inter-individual variability in response to drug treatment has induced an
increased demand for decisions via personalize medicine. Also, the contribution of …

Proteome analysis has been applied in multiple studies in the context of chronic kidney
disease, aiming at improving our knowledge on the molecular pathophysiology of the …

Introduction Chronic kidney disease is avery common and complex chronic disease.
Uncovering the pathological patterns of CKD on the molecular level of bio-fluids and tissue …

Chronic kidney disease (CKD) is a serious health burden affecting approximately 16% of the
world population. Chronic kidney disease is associated with gradual loss of kidney function …

Abstract Treatment effectiveness for kidney disease is limited by lack of accuracy, sensitivity,
specificity of diagnostic, prognostic, and therapeutic biomarkers. The gold standard test …

Kidney disease is one of the fastest growing causes of death worldwide, disclosing an
unmet clinical need for early diagnosis and optimized risk stratification that allows high risk …

Since the publication of the first volume on proteomics in nephrology, methodologies and
protocols for renal and urinary proteome analyses have been continuously improved …

Current biomedical applications of proteomics have been conducted with four main
objectives: to better understand the normal biology and physiology of cells, microorganisms …

BACKGROUND Technological advances have resulted in a renaissance of proteomic
studies directed at finding markers of disease progression, diagnosis, or responsiveness to …